Parkinson’s disease is set to rise dramatically, with cases expected to more than double by 2050, largely due to an aging ...

People with Parkinson's disease who have a pacemaker-like device implanted in the brain spend an extra four-plus hours a day free of tremors and involuntary movements than they do on medication, ...

Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...

Northwestern Medicine investigators have uncovered new insights into how metabolic dysfunction contributes to Parkinson's ...

Researchers studying brain waves have suggested that a new discovery they have made could hold the key to treating anxiety in people diagnosed with P ...

Noida: A native of Kazakhstan, who had been experiencing locomotor disability for the last 14 years, as a side effect of ...

A decade after scientists at The Picower Institute for Learning and Memory at MIT first began testing whether sensory ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

This recent study highlights the neuroprotective potential of TFE3, a transcription factor that plays a pivotal role in counteracting key pathological mechanisms associated with Parkinson's disease ...

The U.S. Food and Drug Administration (FDA) has announced several significant developments this week, spanning advancements ...

Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

There is no cure for Parkinson's, and over one million people have the disease in the United States alone. However, deep brain stimulation (DBS) has been used to treat this and other neurological ...